Back to AVTX

CITADEL ADVISORS LLC → AVTX

CITADEL ADVISORS LLC AVTX Position History

Avalo Therapeutics, Inc. • Healthcare

Quarters held
6
Latest value
$255K
Q2 2026
Peak value
$6M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$2.1M
Q2 2026$6M
Q2 2026$255K
Q2 2026$2.1M
Q2 2026$6M
Q2 2026$255K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$255K13.8K——
Q2 2026$6M323.8K——
Q2 2026$2.1M112.6K——
Q2 2026$255K13.8K——
Q2 2026$6M323.8K——
Q2 2026$2.1M112.6K——

Other funds holding AVTX

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
SPY

SPDR S&P 500 ETF TR

$3B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.1B
SPY

SPDR S&P 500 ETF TR

$2.1B
NVDA

NVIDIA CORPORATION

$2.1B